Bastian Beitzinger

Bastian Beitzinger

Auto-generated profile, based on publicly available information

Bastian Beitzinger

Inorganic Chemistry II Ulm University Albert‐Einstein‐Allee 11 89081 Ulm Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
BBBastian Beitzinger
Bastian Beitzinger
FGFabian Gerbl
Fabian Gerbl
TVThomas Vomhof
Thomas Vomhof
RSRoman Schmid
Roman Schmid
RNReiner Noschka
Reiner Noschka
SSSteffen Stenger
Steffen Stenger
Tuberculosis remains a serious global health problem causing 1.3 million deaths annually. The causative pathogen Mycobacterium tuberculosis (Mtb) has developed several mechanisms to evade the immune system and resistances to many conventional antibiotics, so that alternative treatment strategies are urgently needed. By isolation from bronchoalveolar lavage and peptide optimization, a new antimicrobial peptide named NapFab is discovered. While showing robust activity against extracellular Mtb, the activity of NapFab against intracellular bacteria is limited due to low intracellular availability. By loading NapFab onto dendritic mesoporous silica nanoparticles (DMSN) as a carrier system, cellular uptake, and consequently antimycobacterial activity against intracellular Mtb is significantly enhanced. Furthermore, using lattice light‐sheet fluorescence microscopy, it can be shown that the peptide is gradually released from the DMSN inside living macrophages over time. By electron microscopy and tomography, it is demonstrated that peptide loaded DMSN are stored in vesicular structures in proximity to mycobacterial phagosomes inside the cells, but the nanoparticles are typically not in direct contact with the bacteria. Based on the combination of functional and live‐cell imaging analyses, it is hypothesized that after being released from the DMSN NapFab is able to enter the bacterial phagosome and gain access to the bacilli.


27 July 2025 in Advanced Science
Verified
Journal Article
Open access
SSSimon Schauer
Simon Schauer
BBBastian Beitzinger
Bastian Beitzinger
GNGregor Neusser
Gregor Neusser
CKChristine Kranz
Christine Kranz
MLMika Lindén
Mika Lindén
Co‐precipitation is an attractive means for synthesizing mixed metal oxides, a material class with a wide range of application prospects. Often soluble metal salts are precipitated as metal hydroxides or ‐carbonates, which subsequently are converted to the corresponding oxide(s) upon thermal treatment. The thermal treatment step is used to induce compositional homogeneity on the atomic level. In order to shed some more light on this effect, detailed analyses of a mixed Li‐Ni‐Mn‐oxide with the target composition LiNi 0.5 Mn 1.5 O 4 (LNMO), which is a promising cathode material for rechargeable Li‐ion batteries are performed. The first synthesis step is the precipitation of a Ni‐Mn‐carbonate, which is subsequently thermally lithiated and transformed into an oxide. A combination of X‐Ray diffraction (XRD), Raman microscopy, scanning electron microscopy coupled with energy dispersive X‐Ray spectroscopy (EDX) in combination with elemental analysis, as well as electrochemical characterization, revealed that chemical inhomogeneities present already in the precursor particles have a direct influence on the electrochemical performance of the final product. The broader implications of these results in relation to co‐precipitation‐based syntheses of functional materials are discussed, with special focus on the importance of the particle size distribution of the secondary particles.